Related Experiment Video
Updated: Oct 1, 2026

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
Published on: April 18, 2025
[Antibiotic activity of P. aeruginosa against MRSA and Candida albicans]
Shigemi Kondo1, Naotake Sato, Toshihiko Yamada
1Department of Clinical Pathology, Juntendo University School of Medicine.
Abstract:
The antibiotic activity demonstrated by P. aeruginosa (Bacillus pyocyaneus) has been reported more than one hundred years ago by Emmerich et al (1899). Studies on such bacterial interference between P. aeruginosa and other pathogenic bacteria or fungi have not been extensively reported in recent years. In this paper, we report on the anti MRSA activity and anti Candida activity demonstrated by clinical isolates of P. aeruginosa (34 strains). The antibiotic activity was tested by reversed agar plate method, as previously reported, and the degree of the activity was expressed as the diameter of the zone of growth inhibition. The stability of both anti MRSA activity and anti Candida activity was evaluated at the time after 24 and 48-hr incubation. Also the effect of agar plate with or without 5% sheep blood on antibiotic activity was evaluated. Strong anti MRSA activity and anti Candida activity was shown at the time after 24-hr incubation. At the time after 48-hr incubation, anti MRSA activities were significantly suppressed but anti Candida activities were persisted. The inhibitory activity was correlated with dye production of P. aeruginosa. Some strains having non or weak dye production, showed the inhibitory activity by 48-hr incubation. Result from these strains without suppression of anti Candida activity by additional blood may suggest that the existence of a new factor produced by P. aeruginosa. Because of frequent isolation of MRSA or Candida from clinical materials, we must consider bacterial flora and bacterial interference against pathogenic bacteria at the time of the antibiotic choice for the patients infected or colonized with P. aeruginosa.
Insights
Pseudomonas aeruginosa exhibits antibiotic activity against MRSA and Candida. This bacterial interference persists against Candida longer than against MRSA, suggesting a novel inhibitory factor.
Area of Science:
- Microbiology
- Bacterial Interference
- Antimicrobial Activity
Background:
- Bacterial interference by Pseudomonas aeruginosa (Bacillus pyocyaneus) was noted over a century ago.
- Recent studies on P. aeruginosa's interference with pathogens are limited.
- Methicillin-resistant Staphylococcus aureus (MRSA) and Candida species are significant clinical threats.
Purpose of the Study:
- To investigate the anti-MRSA and anti-Candida activities of clinical P. aeruginosa isolates.
- To evaluate the stability and factors influencing this antibiotic activity.
Main Methods:
- Tested 34 clinical P. aeruginosa strains for antimicrobial activity using the reversed agar plate method.
- Assessed activity after 24 and 48-hour incubations.
- Evaluated the impact of 5% sheep blood on agar plates.
Main Results:
- Strong anti-MRSA and anti-Candida activity observed at 24 hours.
- Anti-MRSA activity decreased significantly by 48 hours, while anti-Candida activity persisted.
- Inhibitory activity correlated with dye production; non-dye-producing strains showed sustained anti-Candida activity.
- Persistence of anti-Candida activity, even with added blood, suggests a novel P. aeruginosa factor.
Conclusions:
- Clinical P. aeruginosa isolates possess significant, albeit variable, antibiotic activity against MRSA and Candida.
- Anti-Candida activity is more stable than anti-MRSA activity.
- A potential new inhibitory factor produced by P. aeruginosa warrants further investigation.
- Bacterial interference should be considered when choosing antibiotics for patients with P. aeruginosa colonization or infection.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
